Inventor · disambiguated record
Douglas J. Macneil
Also filed as: MACNEIL DOUGLAS · MACNEIL DOUGLAS J · MACNEIL DOUGLAS JOHN
15 granted patents·9 pending applications·465 citations·filing 1990–2008
94Inventor score
Top patents by PatentIndex Score
24 records- 0196US6313298B1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 2000·Granted Nov 6, 2001·79 cites·21 claims
- 0292US6191160B1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 1999·Granted Feb 20, 2001·79 cites·15 claims
- 0391US5252474ACloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their useMERCK & CO INC·Filed 1990·Granted Oct 12, 1993·119 cites·46 claims
- 0489US5908830ACombination therapy for the treatment of diabetes and obesityMERCK & CO INC·Filed 1997·Granted Jun 1, 1999·113 cites·20 claims
- 0586US6693184B1DNA molecules encoding splice variants of the human melanocortin 1 receptor proteinMERCK & CO INC·Filed 2001·Granted Feb 17, 2004·12 cites·18 claims
- 0680US6638942B1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 2002·Granted Oct 28, 2003·10 cites·13 claims
- 0774US6495559B2NPY Y5 receptor antagonistsMERCK & CO INC·Filed 2001·Granted Dec 17, 2002·5 cites·16 claims
- 0863US6001970AModified human neuropeptide Y1 ReceptorsMERCK & CO INC·Filed 1995·Granted Dec 14, 1999·20 cites·2 claims
- 0960US7029865B2DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkeyMERCK & CO INC·Filed 2003·Granted Apr 18, 2006·0 cites·4 claims
- 1056US2004063942A1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 2003·Application pending·0 cites
- 1155US2007099884A1Combination therapy for the treatment of diabetesERONDU NGOZI E·Filed 2004·Application pending·0 cites
- 1252US6573070B1DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkeyMERCK & CO INC·Filed 1999·Granted Jun 3, 2003·6 cites·28 claims
- 1352US2006160834A1Combination therapy for the treatment of hypertensionFONG TUNG M·Filed 2004·Application pending·0 cites
- 1452US2004122033A1Combination therapy for the treatment of obesityFiled 2003·Application pending·0 cites
- 1551US2006270650A1Combination therapy for the treatment of obesityMACNEIL TANYA·Filed 2006·Application pending·0 cites
- 1650US2005288213A1Combination therapy for the treatment of obesityMACNEIL DOUGLAS J·Filed 2003·Application pending·0 cites
- 1748US5621079ANeuropeptide Y receptorMERCK & CO INC·Filed 1995·Granted Apr 15, 1997·10 cites·8 claims
- 1846US5939263ANeuropeptide Y receptorMERCK & CO INC·Filed 1996·Granted Aug 17, 1999·5 cites·35 claims
- 1941US5312753AStrain of streptomyces avermitilis capable of glycosylating avermectin compounds at the 13- and 14A positionsMERCK & CO INC·Filed 1992·Granted May 17, 1994·3 cites·2 claims
- 2038US7179886B1Cloning and identification of the motilin receptorMERCK & CO INC·Filed 1999·Granted Feb 20, 2007·2 cites·5 claims
- 2138US2009104210A1Peptide compounds for treating obesity and insulin resistanceTOTA MICHAEL R·Filed 2008·Application pending·0 cites
- 2237US2008064632A1Combination Therapy for the Treatment of ObesityAMATRUDA JOHN M·Filed 2005·Application pending·0 cites
- 2336US2005107411A1Method for treating circadian rhythm disruptionsFiled 2002·Application pending·0 cites
- 2434US5194387AProcess for the incorporation of DNA molecules into microorganisms with methyl-specific restriction systemsMERCK & CO INC·Filed 1991·Granted Mar 16, 1993·2 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Douglas J. Macneil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →